Berczi
I, Bereznay T, Bertók L. Examination of swine and calf diseases
due to Escherichia coli. Proc. 9th International Congress for
Microbiology, Moscow, July 24- 30, 1966;433.
[2]
Berczi
I, Sabbadini E, Sehon AH. In vivo destruction of tumor cells mediated by
an indirect cellular immune mechanism. Proc Can Fed Biol Soc 1970;13:132,
Abstract No.409.
[3]
Berczi
I, Sabbadini E, Sehon AH. In vivo destruction of tumor cells mediated by
an indirect cellular immune mechanism. Proc Can Fed Biol Soc 1972;15:
Abstract No. 362.
[4]
Froese
G, Berczi I. Enhancement of the primary immune response in guinea pigs
by X- irradiation. Physics in Canada 1972;28:19, Abstract No. BG7.
[5]
Froese
G, Berczi I, Sehon AH. Immunogenicity of B16 melanoma. Proc Can Fed Biol
Soc 1973;16:108, Abstract No. 431.
[6]
Berczi
I, Tsay HM, Sehon AH. In vivo and in vitro rejection of tumor cells transplantable
in inbred guinea pigs. Proc Can Fed Biol Soc 1973;16:109, Abstract
No. 435.
[7]
Froese
G, Linford JH, Berczi I, Israels LG. An ankylating agent-globulin conjugate
with both alkylating and antibody activity. Proc Can Fed Biol Soc
1974;17:88, Abstract No. 351.
[8]
Huang
JC-C, Berczi I, Froese G, Sehon AH. Detection of syngeneic and xenogeneic
antibodies to tumor cells by an indirect micro-radioimmunoassay (RIA).
Proc Can Fed Biol Soc 1974;17:89, Abstract No. 356.
[9]
Berczi
I, Tsay HM, Huang JC-C, Yong DCT, Sehon AH. A rapid radioimmunoassay for
determination of tumor antigens with reference to carcinoembryonic antigen.
Proc Can Fed Biol Soc 1975;18:135, Abstract No. 537.
[10]
Berczi
I, Sehon AH. Cell mediated immunity against syngeneic guinea pig tumor
cells in vitro. Proc Can Fed Biol Soc 1975;18:135, Abstract No. 539.
[11]
Berczi
I, Lee WY, Sehon AH. A rapid radioimmunoassay for determination of tumor
antigens with reference to carcinoembryonic antigen. Proc. 24th Annual
Collogium on "Protides of the Biological Fluids," Brugge, Belgium,
1976;46, Abstract No. 75.
[12]
Berczi
I, Simieritsch B, McMorris LS, Thorlakson TK, Thorlakson RH, Sehon AH.
Antibody response by colon carcinoma patients to a tumor antigen. Proc
Can Fed Biol Soc 1976;19:94, Abstract No. 374.
[13]
Froese
G, Linford JH, Berczi I, Sehon AH, Israels LG. Specific destruction of
tumor cells by Trenimon-antibody conjugates. Proc Amer Assoc Cancer
Res 1976;17:30, Abstract No.120.
[14]
Abe
S, Berczi I, Sehon AH. Lysis of guinea pig hepatoma line-10 by specific
antibody and guinea pig complement. Fed Proc 1976;35:472, Abstract
No. 1471.
[15]
Lee
FH, Berczi I, Fujimoto S, Sehon AH. Complete regression of an established
tumor by Daunomycin conjugated to anti-fibrin antibodies. Fed Proc
1977;36:1242, Abstract No. 5154.
[16]
Berczi
I, Sehon AH. Tumor inhibition by effector cells induced either in vitro
or cultured from progressing sarcomas. Fed Proc 1977;36:1306, Abstract
No. 5493.
[17]
Abe
S, Berczi I, Sehon AH. Resistance of hepatoma cells to complement mediated
lysis induced by ascites fluid or serum from tumor bearing guinea
pigs. Proc Amer Assoc Cancer Res 1977;18:209, Abstract No. 836.
[18]
Berczi
I, Sehon AH, Kovacs K, Horvath E. Rejection of tumor cells in vitro: Morphological
studies on killer T cells and damaged tumor cells. Proc Can Fed Biol Soc
1977;20:13, Abstract No. 51.
[19]
Berczi
I, Sehon AH. Effector and suppressor lymphoid cells in tumor-bearing guinea
pigs. Proc. Amer. Assoc. Cancer Res. 1978;19, Abstract No. 748.
[20]
Froese
G, Berczi I, Cormack DV. Quantitative binding of antibody to L5178Y tumor
cells in vitro and the kinetics of the distribution of antibody and
normal IgG in tumor- bearing and tumor-free mice. Fed Proc 1978;37:1381,
Abstract No. 614.
[21]
Froese
G, Berczi I, Cormack DV. The destruction of antibody by tumor cells. Proc
Can Fed Biol Soc 1978;21:118, Abstract No. 472.
[22]
Berczi
I, Wang KC, Hoffman EG, Sehon AH. Effector and suppressor lymphoid cells
in various tumor-host systems. Proc Can Fed Biol Soc 1978;21:119,
Abstract No. 473.
[23]
Nagy
E, Berczi I. Immunodeficiency in hypophysectomized rats. Fed Proc 1979;38:1355,
Abstract No. 5957.
[24]
McComb
DI, Ryan N, Horváth E, Kovács K, Nagy E, Berczi I, Domokos
I, Laszlo FA. Ultrastructural immunocytochemistry of five rat pituitary
adenomas. Proc. 38th Annual Meeting of the Electron Microscopy Society
of America, 1980;724-725.
[25]
Berczi
I, Nagy E. Impaired antibody response in hypophysectomized rats. Proc 4th
Int Cong Immunol 1980; Abstract No. 7.4.01.
[26]
Berczi
I, Nagy E. Immunodeficiency in hypophysectomized rats: Restoration by
prolactin. Fed Proc 1981;40:1031 Abstract No. 4541.
[27]
Berczi
I, Nagy E. Prolactin and immunity. Proc Can Fed Biol Soc 1981;24:148 Abstract
No.189.
[28]
Berczi
I, Nagy E. Immunoregulation by pituitary hormones. Fed Proc 1982;41:816
Abstract No. 3193.
[29]
Berczi
I, Nagy E. Immunoregulation and prolactin. Proc Can Fed Biol Soc 1982;25:25,
Abstract No. 91.
[30]
Froese
G, Berczi I. The interaction of monoclonal antibody and tumor cells. Proc
Can Fed Biol Soc 1982;25:31, Abstract No. 113.
[31]
Berczi
I, Nagy E, Wren GE. Pituitary function and immunity. Presented at the 5th
Int. Cong. of Immunology, Kyoto, Japan, August 21-27,1983.
[32]
Berczi
I. Immunoregulatory aspects of pituitary function. Symposium Hans Selye,Universite
de Montreal, Montreal, Quebec, Canada, October 21-22,1983.
[33]
Berczi
I, Nagy E, Friesen HG, Sehon AH. Immunomodulation in rats by transplantable
pituitary tumors. Fed Proc 1983;43:1620, Abstract No. 1192.
[34]
Berczi
I, Nagy E, Asa SL, Kovacs K. The influence of pituitary hormones on adjuvant
arthritis. 7th International Congress of Endocrinology, Quebec City,
Canada, July1-7,1984.
[35]
Froese
A, Chan BMC, Roth PA, Rao M, McNeill K, Berczi I. Structural modification
of Fc receptors for IgE by mycoplasma. 6th International Congress
of Immunology, July, 1986;6-11, Toronto, Canada, Abstract No. 2.61.14.
[36]
MacDonald
GC, Primrose S, Biggins K, Bowman JM, Berczi I, Friesen AD, Sehon AH.
Human Rho-(D) specific monoclonal antibodies. Proc. 6th International Congress
of Immunology, July 6-11,1986, Toronto, Canada. Abstract No. 3.16.13.
[37]
Berczi
I, Nagy E, McKenzie CE, Wren GE, Houston G. Pituitary control of
hemolymphopoietic tissue and immune function. 6th International Congress
of Immunology, July 6-11, 1986, Toronto, Canada. Abstract No. 3.63.10.
[38]
Berczi
I, Nagy E. Immunomodulation by tamoxifen and pergolide. 14th International
Cancer Congress, Budapest, Hungary, August 21-27, 1986; Abstract
No. 2521.
[39]
Ramachandra
RN, Berczi I, Sehon AH. Neutralization of the biological effects of lipid
A by human monoclonal antibodies. FASEB, 73rd Annual Meeting, New
Orleans, March 19-23, 1989; Abstract No. 4016.
[40]
Zheng
Y, Chan BMC, Berczi I, Froese A. Establishment and characterization of
hybrid mast cells. 7th International Congress of Immunology, July
30-August 5,1989, Berlin, West Germany. Abstract No. 76-17.
[41]
Ramachandra
RN, Berczi I, Sehon AH. Neuro-immune host defence in endotoxin shock.7th
International Congress of Immunology, July 30-August 5, 1989, Berlin, West
Germany. Abstract No. 92-79.
[42]
Berczi
I, Nagy E. Pituitary dependence of bone marrow function. 7th International
Congress of Immunology, July 30-August 5, 1989, Berlin, West Germany. Abstract
No. 93-10.
[43]
Ramachandra
RN, Berczi A, Berczi I, Sehon AH. Murine monoclonal lipid A specific
antibodies cross-react with and neutralize the biological and toxic effects
of endotoxin derived from various Gram-negative bacteria. Fourth
Spring Meeting of Canadian Society of Immunology (CSI), March 9-12,
1990, Auberge Mont Gabriel, Mont Rolland, Quebec, Canada. Abstract
No. 1-20.
[44]
Berczi
I. Neuroimmunoregulatory hormones. 1st International Congress ISNIM, May
23-26,1990, Florence, Italy. Abstract No. 106.
[45]
Berczi
I, Nagy E, Matusik RJ, Friesen HG.Pituitary hormones regulate c-myc and
DNA synthesis in lymphoid tissue. 1st International Congress ISNIM,
May 23-26, 1990, Florence, Italy. Abstract No. 120.
[46]
Berczi
I, Nagy E, Baral E. The amplification of cell-mediated cytolysis by estradiol
and tamoxifen. 8th International Congress of Immunology, Budapest,
Hungary August 23-28, 1992.
[47]
Bose
R, Nagy E, Berczi I, Yang J. Production and characterization of murine
monoclonal antibodies to human embryo associated immunosuppressor
factor (EASF). Proc Soc Gynecol Invest 1992; Abstract No. 512.
[48]
Berczi
I. Prolactin, growth hormone and immunocompetence. Proc of the 4th NAITO
Conference on Neuro-Immuno-Endocrine Networks, November 25-28, 1994, Gifu,
Japan. Abstract No. B-6, p. 28-29.
[49]
Baral
E, Berczi I, Nagy E, Krepart G, Kangas L. Potentiation of cancer immunotheapy
by antiestrogens. Symposium to European Conference for Clinical Oncology,
October 31, 1995, Paris, Toremifene, Adding Safety to Antiestrogen
Therapy. Pp. 87.
[50]
Berczi
I, Nagy E, Chow DA, Baral E. Regulation of killer cell-induced apoptosis
by steroid hormones. Cellular and Molecular Biology 42, Suppl.
Congres., 1996; Abstract 2, page S-1 to S-2.
[51]
Berczi
I. Neurohormonal host defence in endotoxin shock. 3rd International Congress
of the International Society for Neuroimmunomodulation, Bethesda,
MD, November 13- 15, 1996. NeuroImmunoModulation 1996;3:181.
[52]
Berczi
I. Pituitary hormones and immune function. Proc. 23rd International Symposium
on: "Growth hormones and growth factors in endocrinology and metabolism."
Paris, April 11-12, 1997.
[53]
Berczi
I. Neuroimmunoregulation in health and disease. Proc. Fourth International
Congress of Immunology & Allergy, Isfahan, Iran, May 13-15,1998.
[54]
Haeryfar
SMM, Nagy E, Baral E, Berczi I.The enhancement of killer cell-induced
cytolysis by antiestrogens.Proc. Fourth International Congress of Immunology
& Allergy, Isfahan, Iran, May 13-15,1998;105.
[55]
Berczi
I, The stress concept and neuroimmunoregulation in modern biology. Proc.Int.
Symposium on: Stress of life. Stress and adaptation from molecules to man.
Budapest, Hungary, July 1-5, 1997.
[56]
Nagy
E, Krepart G, Baral E, Berczi I, Kellen JA. Gene expression and immune
cytolysis of human ovarian carcinoma cells, treated with toremifene
and interferon-alpha. Anticancer Res 1998;18:4893.
[57]
Berczi
I, Chow DA, Sabbadini E. Neuroimmunoregulation and natural immunity.
Proc.International Workshop on: "Immune-Endocrine Interactions ".
Bundesforschungsanstalt für Landwirtschaft. Institut für tierzucht
und tierverhalten, Mariensee, Germany, November 21-22, 1997.
[58]
Berczi
I, Nagy E, Haeryfar M, Krepart G, Lotocki R, Unruh H, Baral E. Combination
immunotherapy of cancer with killer cells, cytokines and antiestrogens.
Cancer Detection and Prevention 1998, 22 (Supplement 1), CDP Meeting,
Nice, France. 1998.
[59]
Haeryfar,
SMM, Nagy E, Baral E, Berczi I. Antiestrogens affect Fas/Fas ligand and
perforin/granzyme pathways of immune cytolysis. Proc. 42nd meeting of the
Canadian Federation of Biological Societies, Winnipeg, June 2-5,1999.
Abstract No. 134.
[60]
Beczi
I, Bertok L, Chow DA. Natural immunity and neuroimmune host defence. Proc.
4th International Congress of the International Society for Neuroimmunomodulation,
Lugano, Switzerland, Sept. 29 - Oct. 2, 1999.
[61]
Berczi
I. Growth hormone, prolactin and immune function. Proc. International
Symposium on Growth Hormone in Immune Reconstitution. St. Petersburgh Beach,
Florida, USA, October 7-10, 1999.
[62]
Berczi
I. Neuroimmune Biology: An Introduction. Proc. Canadian symposium on
Neuroimmune Biology, Winnipeg, June 9-12, 2000.
[63]
Nagy
E, Berczi I, Baral E. Combination immunotherapy of cancer. Proc. Canadian
symposium on Neuroimmune Biology, Winnipeg, June 9-12, 2000.
[64]
Berczi
I. Toxic insults and the neuroimmune regulatory network. Proc First International
Conference on Metals and the Brain. Padova, Italy Sept 20-23, 2000.
[65]
Berczi
I, Szentivanyi A. Neuroimmune Biology. Current status and future perspectives.
Proc. International Conference on Allergy, Immunology and Global Network:
Insights into the next milleneum. New York, USA, April 14-17, 2001.
[66]
Berczi
I. The neuroimmune biology of growth and lactogenic hormones. Proc.
International Conference on Allergy, Immunology and Global Network. Cannes,
France, April 21-24, 2002.
[67]
Berczi
I, Nagy E, Sabbadini ER, McCarthy T, Warrington R. Salivary immunoregulation
and autoimmune disease. Proc. 5th International Congress of the International
Society for Neuroimmunomodulation, Montpellier, France, September
9-11, 2002.
[68]
Berczi
I.: “The Immune Neuroendocrine Circuitry” , Proc. Symposium on Neuroendocrine
Immunology, for the 30th anniversary of the Scientific Research Institute,
Free University of Aguascalientes, Aguascalientes, Mexico. May 2003.
[69]
Berczi
I, Szentivanyi A. “ The Neuroimmune Regulatory Network”, Proc. Sixth International
Conference of the Polish Neuroscience Society, Warsaw, Poland, July 16-19,
2003.
[70]
Quintanar-Stephano
Andrés, Organista-Esparza Alejandro, Tinajero-Ruelas Manuel, Chavira-Ramírez
Roberto, Medina-Fernández Maribel, Sánchez-Herrera I Omar, Berczi Istvan and
Kovacs Kalman. Effects of Neurointermediate Pituitary Lobectomy and
Desmopressin on Experimental Autoimmune Encephalomyelitis in Rats.
Experimental Biology 2004. FASEB Meeting. Washington. D.C. USA. 17-21 April,
2004.
[71]
Quintanar-Stephano
Andrés, Organista-Esparza Alejandro,Chavira-Ramírez
Roberto,Kovacs Kalman,Berczi Istvan , Efectos
de la lobectomía neurointermedia hipofisiaria y desmopresina sobre la
encefalomielitis experimental autoinmune aguda y el eje hipotalamo-hipófisis-Adrenal
en la rata lewis. 5º Seminario de Investigación. Universidad Autónoma
de Aguascalientes. Aguascalientes.Ags.Agosto, 2004.
[72]
Quintanar-Stephano, A., Organista-Esparza, A., Tinajero-Ruelas, M., Chavira-Ramírez, R.,
Gonzalez-Delgado, E., Garcia, D., Ramirez, E., Rodriguez, E., Berczi, I., and Kovacs, K.Protection
Against Adjuvant-induced Arthritis (AIA) by the Excision of the Neuro-intermediate
Pituitary Lobe (NIL) in Lewis Rats. Experimental Biology 2005. Meeting. San
Diego, CA. USA.FASEB Proc. Abstract Number 7407.
[73]
Berczi I, Quitanar Stephano A,
Kovacs K. Immunoconversion and reversion in the acute phase response. Proc. 6th
international conference of the International Society for NeuroImmunoModulation,
Athens, Greece, p 64, Abstract No 9. September 25-28, 2005.
[74]
Blockade of immune cell-vasopressin receptors by V1a antagonist inhibit the
peak of the experimental autoimmune encephalomyelitis in Lewis rats. Quintanar Stephano Andrés, Organista Alejandro, Tinajero Manuel, Rodríguez Chavira Roberto, González
Evangelina, García Diego, Sánchez I. Omar, Berczi Istvan and Kovacs Kalman.FASEB Proc. 918.10, 1. San Francisco, Califiornia. USA. 1-5 April. 2006.
[75]
Blockade of immune-cell vasopressin receptors. V1a antaginists inhibit the peak of the
experimental autoimmune encephalomyelitis in Lewis rats. Quintanar-Stephano Andrés, Kalman Kovacs and Istvan
Berczi. Experimental Biology 2006. FASEB Meeting. San Francisco, Califiornia. USA. 1-5 April. 2006.
[76]
Posible protección contra la encefalitis y artritis experimentales por antagonistas
de la vasopresina (Papel de la vasopresina en la encefalitis experimental
autoinmune). Andrés Quintanar Stephano, Roberto Chavira Rodríguez, Alejandro
Organista Esparza, Evangelina Delgado González, Manuel Tinajero Ruelas,
Beatriz Campos Tenorio, María Cruz Reyes Echeverría, Diego De Jesús García
Gallegos, Istvan Berczi y Kalman Kovacs. Séptimo Seminario de Investigación.
Universidad Autónoma de Aguascalientes. 16-19 de Mayo. 2006.
[77]
Recent Insights into Hypothalamic Immunoregulation.
Istvan Berczi, AndresQuintanar Stephano and Kalman Kovacs. Congresso Nacionales de Ciencias
Fiziol gicas, Queretaro, Mexico, Sept 2-3,2006
[78]
Stress and Host Defence.
Istvan Berczi, Andres Quintanar Stephano, Kalman Kovacs. Proc.Hans Selye
Centennial Symposium: Stress: Basic Mechanisms and Clinical Implications. University
of Quebec, Montreal, July 11-14, 2007,Pp. 33
[79]
Stress, Host Defence and
Healing. Istvan Berczi, Andres Quintanar Stephano, Kalman Hovacs. Proc. Second
International Congress on Stress, Budapest, Hungary, August 23-26, 2007, pp
255/5C-03-P
[80]
Neuroimmune regulation in
immunocompetence, acute illness and healing. Istvan Berczi, Andres Quintanar
Stephano and Kalman Kovacs. Proc VII. INSNIM Congress, Rio de Janeiro, April
24-27, 2008. pp13.
[81]
Role of the neurohipophysis on
spleen cytokine MRNA expression and macrophage number in AIA. Quintanar-Stephano,
A., Willalobos, C., Gonzales, E., Organista, A., Tinajero, M., Chavira R,
Campos, R., Riviera JC., Reyna, H., Munoz, M., Ventura, J., Kovacs, K.,
Berczi, I. Abstrcat No. A3, Proc VII. INSNIM Congress, Rio de Janeiro, April
24-27, 2008. pp.34
[82]
The role of natural immunity in
the neuroimmune regulatopy system.Istvan Berczi, Andres Quintanar Stephano and
Kalman Kovacs. International Course on Natural Immunity and Infectious
diseases. Augut 25-Sept.2, 2008. University of Augascalientes, Augascalientes,
Mexico.
[83]
Immunoregulation by the neurohypohysys. Quintanar-Stephano A., Villalobos C, Arroyo K,
Organista A, Tinajero M., Chavira R., Campos R, Reyna H, Muñoz M, Ventura J, Kovacs K, and Berczi I. International Symposium on Interaction of the nervous and immune systems in health and disease. June 16-19 2009, Saint-Petersburg, Russia
[84]
Neuroimmune Regulation of Natural Immunity. Andres Quintanar-Stephano, Kalman Kovacs, Istvan
Berczi. International Symposium on Interaction of the nervous and immune systems in health and disease.
June 16-19 2009, Saint-Petersburg, Russia.
[85]
Immune Host Defense: The Entire Organism Fights for Survival. Istvan
Berczi, Andres Quintanar Stephano and Kalman Kovacs. International Course on Natural Immunity and Infectious diseases. August
30-Sept.10, 2010. University of Augascalientes, Augascalientes, Mexico.
